Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-23-005606
Filing Date
2023-07-28
Accepted
2023-07-28 17:17:39
Documents
106
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q curr_10q.htm   iXBRL 10-Q 1015710
2 CERTIFICATION curr_ex311.htm EX-31.1 9457
3 CERTIFICATION curr_ex312.htm EX-31.2 10340
4 CERTIFICATION curr_ex321.htm EX-32.1 4898
5 CERTIFICATION curr_ex322.htm EX-32.2 4817
  Complete submission text file 0001477932-23-005606.txt   6736585

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA curr-20230331.xsd EX-101.SCH 95223
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE curr-20230331_lab.xml EX-101.LAB 436760
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE curr-20230331_cal.xml EX-101.CAL 66706
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE curr-20230331_pre.xml EX-101.PRE 367422
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE curr-20230331_def.xml EX-101.DEF 190892
100 EXTRACTED XBRL INSTANCE DOCUMENT curr_10q_htm.xml XML 1161015
Mailing Address 5805 SEPULVEDA BLVD., SUITE 801 SHERMAN OAKS CA 91411
Business Address 5805 SEPULVEDA BLVD., SUITE 801 SHERMAN OAKS CA 91411 424-273-8675
Avenir Wellness Solutions, Inc. (Filer) CIK: 0001643301 (see all company filings)

EIN.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55908 | Film No.: 231124184
SIC: 2834 Pharmaceutical Preparations